 |
Video: Compound Annual Growth Rate (CAGR) Definition
|
 |
| Date |
Open |
High |
Low |
Close |
Volume |
| 06/01/2026 |
$32.17 |
$32.45 |
$30.60 |
$31.14 |
1.65M | | 06/02/2026 |
$30.34 |
$30.48 |
$28.80 |
$28.96 |
1.77M | | 06/03/2026 |
$28.71 |
$29.65 |
$28.30 |
$29.55 |
1.16M | | 06/04/2026 |
$29.90 |
$34.02 |
$29.80 |
$32.84 |
4.39M | | 06/05/2026 |
$32.56 |
$32.56 |
$28.64 |
$29.40 |
2.37M |
 |
| Beam Therapeutics Inc. is a biotechnology company developing precision genetic medicines through base editing. Co.'s suite of gene editing technologies is anchored by base editing, a technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the deoxyribonucleic acid. Its lead programs are focused on sickle cell disease and alpha-1 antitrypsin deficiency, and it is also advancing programs in other genetic diseases, as well as immunology/oncology. Its primary programs include BEAM-101, Engineered Stem Cell Antibody Paired Evasion (ESCAPE), BEAM-302, BEAM-301 and BEAM-201. | |
 |

Beam Therapeutics (BEAM) has the following price history information. Looking back at BEAM historical stock prices for the last five trading days, on June 01, 2026, BEAM opened at $32.17, traded as high as $32.45 and as low as $30.60, and closed at $31.14. Trading volume was a total of 1.65M shares. On June 02, 2026, BEAM opened at $30.34, traded as high as $30.48 and as low as $28.80, and closed at $28.96. Trading volume was a total of 1.77M shares. On June 03, 2026, BEAM opened at $28.71, traded as high as $29.65 and as low as $28.30, and closed at $29.55. Trading volume was a total of 1.16M shares. On June 04, 2026, BEAM opened at $29.90, traded as high as $34.02 and as low as $29.80, and closed at $32.84. Trading volume was a total of 4.39M shares. On June 05, 2026, BEAM opened at $32.56, traded as high as $32.56 and as low as $28.64, and closed at $29.40. Trading volume was a total of 2.37M shares.
BEAM Historical Stock Prices By Date:

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Beam Therapeutics shares, starting with a $10,000 purchase of BEAM, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
02/07/2020 |
|
| End date: |
06/05/2026 |
|
| Start price/share: |
$20.62 |
|
| End price/share: |
$29.40 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
42.58% |
|
| Average Annual Total Return: |
5.77% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$14,259.95 |
|
| Years: |
6.33 |
|
|
 |
| Date |
Close |
| 06/01/2026 | $31.14 | | 06/02/2026 | $28.96 | | 06/03/2026 | $29.55 | | 06/04/2026 | $32.84 | | 06/05/2026 | $29.40 |
|
 |